Surgery Partners, Inc. announced the pricing of $425.0 million aggregate principal amount of its 7.250% senior unsecured notes due 2032.
The offering is expected to close on December 16, 2025, subject to customary closing conditions.
The net proceeds will be used for general corporate purposes, including repaying outstanding borrowings.
Offering Details
$425.0 million aggregate principal amount of 7.250% senior unsecured notes due 2032 priced.
Use of Proceeds
Intended for general corporate purposes, including repaying outstanding borrowings.
Regulatory Compliance
Offered and sold to qualified institutional buyers in the U.S. and non-U.S. persons under specific regulations.
- Surgery Partners continues its growth strategy by accessing capital through a private offering.
- The pricing of the notes will support the company's financial position and operational objectives.
The completion of this notes offering demonstrates Surgery Partners' commitment to strategic financial management and growth.